Top Story

Phenol, trichloroacetic acid display efficacy in treating acne scars

February 8, 2016

Trichloroacetic acid and phenol each displayed efficacy in treating acne scars; however, the phenol treatment resulted in less severe complications, according to recently published study results.

Researchers in Brazil conducted a single-blinded, self-controlled clinical trial of 15 patients (80% female; mean age, 28.5 years) with ice pick–type and boxcar type atrophic acne scars between April and October 2012.  The chemical reconstruction of skin scars (CROSS) technique was used as treatment, with 88% phenol applied to the left hemiface and 90% trichloroacetic acid (TCA) used on the right hemiface.

FDA News

FDA releases briefing ahead of hearing on infliximab biosimilar

February 8, 2016
The FDA has recently released a briefing document ahead of its scheduled hearing on Feb. 9 to consider the approval of Celltrion’s CT-P13 biosimilar to infliximab…
In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping” — to prevent…
Breaking News

Senate health committee considers seven biomedical innovation bills

February 8, 2016
The U.S. Senate Committee on Health, Education, Labor and Pensions will consider seven bipartisan bills on biomedical innovation tomorrow, Feb. 9, at the first of three…

Rosacea study tops dermatology reads for week

February 8, 2016
Study results showing that rosacea is associated with autoimmune comorbidities was among the most-read article of the past week on widely…
More News Headlines »